Healthcare Services

Global Lung Cancer Surgery Market Revenue Expected To Reach $6.73 Billion By 2030

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Value Of The Lung Cancer Surgery Market Projected To Expand During 2026–2030?

The lung cancer surgery market size has experienced significant expansion over recent years. It is anticipated to grow from $5.33 billion in 2025 to $5.6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The increase observed in the past can be credited to rising lung cancer incidence rates, the expansion of surgical capacities in hospitals, the availability of proficient thoracic surgeons, the increasing use of video-assisted thoracoscopic surgery, and enhanced awareness regarding early-stage lung cancer treatment.

The lung cancer surgery market is anticipated to experience consistent expansion in the coming years. It is projected to achieve a value of $6.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This growth over the forecast period can be attributed to the increasing integration of robotic surgery platforms, a rising demand for precise surgical outcomes, the expansion of specialized cancer care centers, growing investments in surgical technology, and the increasing adoption of enhanced recovery after surgery protocols. Major trends during this period include a greater uptake of minimally invasive surgical techniques, the rising use of robotic-assisted thoracic surgery, a growing preference for lung-preserving procedures, an expansion in the utilization of advanced surgical instruments, and an enhanced focus on post-surgical recovery outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

What Are The Main Drivers Accelerating The Growth Of The Lung Cancer Surgery Market?

The rising occurrence of lung cancer is projected to drive the expansion of the lung cancer surgery market in the future. This condition involves the unchecked multiplication of atypical cells within one or both lungs, potentially disrupting their regular operation. This escalating prevalence of lung cancer stems from extended exposure to air pollution, particularly fine particulate matter. Such microscopic particles are capable of reaching deep into the lungs, triggering inflammation, harming cells, and inducing genetic changes that may result in cancer formation. Surgical intervention for lung cancer contributes to lowering the mortality rate associated with the disease by facilitating the prompt excision of cancerous tumors before their potential dissemination or advancement. As an illustration, in June 2025, data from the Centers for Disease Control and Prevention, a US-based federal government agency, indicated that in 2023, lung cancer caused 131,584 deaths in the United States, subsequent to 218,893 newly reported cases in 2022. Consequently, the increasing incidence of lung cancer is stimulating the expansion of the lung cancer surgery market.

How Is The Lung Cancer Surgery Market Structured Across Different Market Segments?

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

What Trends Are Influencing The Future Of The Lung Cancer Surgery Market?

Leading companies in the lung cancer surgery market are prioritizing the development of innovative technologies, such as robotic-assisted surgeries, to improve surgical accuracy, shorten recovery periods, and enhance patient outcomes. Robotic-assisted surgeries are defined as minimally invasive procedures carried out using robotic systems controlled by surgeons, aiming to boost precision, lessen complications, and better patient rehabilitation results. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, announced the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform provides superior reach and stability to access small, hard-to-reach lung nodules, thus improving the capability to diagnose lung cancer in its earlier stages. Its advanced maneuverability and integration with imaging technologies facilitate more accurate biopsies while minimizing patient discomfort. Designed to expand procedural capabilities and streamline workflow, the platform supports increased clinical confidence and consistency across a broader array of bronchoscopic procedures.

Which Industry Players Are Present In The Lung Cancer Surgery Market?

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Access The Complete Lung Cancer Surgery Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Which Region Holds The Largest Share In The Lung Cancer Surgery Market?

North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Lung Cancer Surgery Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Market 2026, By The Business Research Company

Lung Cancer Diagnostic And Screening Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Non Small Cell Lung Cancer Nsclc Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Non Small Cell Lung Cancer Nsclc Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795